BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1190 related articles for article (PubMed ID: 32146737)

  • 1. [Prospective cohort study of fetal nuchal translucency in first-trimester and pregnancy outcome].
    Tang HR; Zhang Y; Ru T; Li J; Yang L; Xu Y; Duan HL; Wang Y; Wang Y; Hu YL; Zhang Y; Zheng MM
    Zhonghua Fu Chan Ke Za Zhi; 2020 Feb; 55(2):94-99. PubMed ID: 32146737
    [No Abstract]   [Full Text] [Related]  

  • 2. The diagnostic value of a detailed first trimester anomaly scan in fetuses with increased nuchal translucency thickness.
    Tekesin I
    J Perinat Med; 2019 Feb; 47(2):241-246. PubMed ID: 30218607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should cell-free DNA testing be used in pregnancy with increased fetal nuchal translucency?
    Miranda J; Paz Y Miño F; Borobio V; Badenas C; Rodriguez-Revenga L; Pauta M; Borrell A
    Ultrasound Obstet Gynecol; 2020 May; 55(5):645-651. PubMed ID: 31301176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
    Chitayat D; Langlois S; Douglas Wilson R; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of the fetuses with severely increased nuchal translucency thickness in the first trimester.
    Nakamura Y; Fujita S; Yamada K; Song M; Tajima A; Matsumoto J; Kihira C; Kurata Y; Arakawa H; Tamura C
    J Obstet Gynaecol Res; 2020 Oct; 46(10):1977-1981. PubMed ID: 32761738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome].
    Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R
    Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of copy number variation by CMA in fetus with increased nuchal translucency].
    Du L; Xie HN; Zheng J; He M
    Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):671-676. PubMed ID: 30369122
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
    Chen X; Chang Y; Cui HY; Ren CC; Yu BY
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance.
    Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK
    Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of major heart defects by routine first-trimester ultrasound examination: association with increased nuchal translucency, tricuspid regurgitation and abnormal flow in ductus venosus.
    Minnella GP; Crupano FM; Syngelaki A; Zidere V; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2020 May; 55(5):637-644. PubMed ID: 31875326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The utility of detailed first trimester ultrasound examination in abnormal fetal nuchal translucency.
    Bronshtein M; Zimmer EZ; Blazer S
    Prenat Diagn; 2008 Nov; 28(11):1037-41. PubMed ID: 18925580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and outcome of increased nuchal translucency in usmanu danfodiyo university teaching hospital, Sokoto, Nigeria: A cohort study.
    Sulaiman B; Shehu CE; Panti AA; Saidu SA; Onankpa B; Ekele BA
    Niger J Clin Pract; 2020 Jun; 23(6):864-869. PubMed ID: 32525124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of fetal non-chromosomal abnormalities on routine ultrasound examination at 11-13 weeks' gestation.
    Syngelaki A; Hammami A; Bower S; Zidere V; Akolekar R; Nicolaides KH
    Ultrasound Obstet Gynecol; 2019 Oct; 54(4):468-476. PubMed ID: 31408229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fetal anatomy scan with integrated nuchal translucency and combination of PAPP-A and fβhCG for prediction of aneuploidy.
    Kornanova E; Dugatova M; Vaclavova Z; Borovsky M
    Bratisl Lek Listy; 2022; 123(4):299-303. PubMed ID: 35294217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis for the pregnancy outcome of cystic hygroma fetuses and correlation with increased nuchal translucency in first trimester].
    Wang Q; Wang X
    Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):665-670. PubMed ID: 30369121
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse pregnancy outcome in fetuses with early increased nuchal translucency: prospective cohort study.
    Bet BB; Lugthart MA; Linskens IH; van Maarle MC; van Leeuwen E; Pajkrt E
    Ultrasound Obstet Gynecol; 2024 Feb; ():. PubMed ID: 38411313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal exome sequencing analysis in fetal structural anomalies detected by ultrasonography (PAGE): a cohort study.
    Lord J; McMullan DJ; Eberhardt RY; Rinck G; Hamilton SJ; Quinlan-Jones E; Prigmore E; Keelagher R; Best SK; Carey GK; Mellis R; Robart S; Berry IR; Chandler KE; Cilliers D; Cresswell L; Edwards SL; Gardiner C; Henderson A; Holden ST; Homfray T; Lester T; Lewis RA; Newbury-Ecob R; Prescott K; Quarrell OW; Ramsden SC; Roberts E; Tapon D; Tooley MJ; Vasudevan PC; Weber AP; Wellesley DG; Westwood P; White H; Parker M; Williams D; Jenkins L; Scott RH; Kilby MD; Chitty LS; Hurles ME; Maher ER;
    Lancet; 2019 Feb; 393(10173):747-757. PubMed ID: 30712880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of fetal structural anomalies in a basic first-trimester screening program for aneuploidy.
    Bromley B; Shipp TD; Lyons J; Navathe RS; Groszmann Y; Benacerraf BR
    J Ultrasound Med; 2014 Oct; 33(10):1737-45. PubMed ID: 25253819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
    Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
    Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.